Table 1.

Clinicopathological parameters of patients with advanced pancreatic cancer (n = 210)

Parameter	Category	No	%
Age	<65	139	66.2%
	≥65	71	33.8%
Gender	Male	132	62.9%
	Female	78	37.1%
Stage	III	71	33.8%
	IV	139	66.2%
Chemotherapy	Yes	178	84.8%
	No	32	15.2%
CA19‐9 level	<1000 U/mL	130	61.9%
	≥1000 U/mL	80	38.1%
CA125 level	<35 U/mL	88	41.9%
	≥35 U/mL	122	58.1%
Kras G12V	Mutation	61	29%
	None G12V mutation	149	71%
Kras G12D	Mutation	93	44.3%
	None G12D mutation	117	55.7%